Unknown

Dataset Information

0

The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.


ABSTRACT: Cytokines orchestrate the tumor-promoting interplay between malignant cells and the immune system. In many experimental and human cancers, the cytokine TNF-alpha is an important component of this interplay, but its effects are pleiotropic and therefore remain to be completely defined. Using a mouse model of ovarian cancer in which either TNF receptor 1 (TNFR1) signaling was manipulated in different leukocyte populations or TNF-alpha was neutralized by antibody treatment, we found that this inflammatory cytokine maintained TNFR1-dependent IL-17 production by CD4+ cells and that this led to myeloid cell recruitment into the tumor microenvironment and enhanced tumor growth. Consistent with this, in patients with advanced cancer, treatment with the TNF-alpha-specific antibody infliximab substantially reduced plasma IL-17 levels. Furthermore, expression of IL-1R and IL-23R was downregulated in CD4+CD25- cells isolated from ascites of ovarian cancer patients treated with infliximab. We have also shown that genes ascribed to the Th17 pathway map closely with the TNF-alpha signaling pathway in ovarian cancer biopsy samples, showing particularly high levels of expression of genes encoding IL-23, components of the NF-kappaB system, TGF-beta1, and proteins involved in neutrophil activation. We conclude that chronic production of TNF-alpha in the tumor microenvironment increases myeloid cell recruitment in an IL-17-dependent manner that contributes to the tumor-promoting action of this proinflammatory cytokine.

SUBMITTER: Charles KA 

PROVIDER: S-EPMC2752076 | biostudies-literature | 2009 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

The tumor-promoting actions of TNF-alpha involve TNFR1 and IL-17 in ovarian cancer in mice and humans.

Charles Kellie A KA   Kulbe Hagen H   Soper Robin R   Escorcio-Correia Monica M   Lawrence Toby T   Schultheis Anne A   Chakravarty Probir P   Thompson Richard G RG   Kollias George G   Smyth John F JF   Balkwill Frances R FR   Hagemann Thorsten T  

The Journal of clinical investigation 20090908 10


Cytokines orchestrate the tumor-promoting interplay between malignant cells and the immune system. In many experimental and human cancers, the cytokine TNF-alpha is an important component of this interplay, but its effects are pleiotropic and therefore remain to be completely defined. Using a mouse model of ovarian cancer in which either TNF receptor 1 (TNFR1) signaling was manipulated in different leukocyte populations or TNF-alpha was neutralized by antibody treatment, we found that this infla  ...[more]

Similar Datasets

| S-EPMC2858152 | biostudies-literature
| S-EPMC9408897 | biostudies-literature
| S-EPMC10572174 | biostudies-literature
2010-03-07 | E-GEOD-19272 | biostudies-arrayexpress
| S-EPMC5376972 | biostudies-literature
2010-03-01 | GSE19272 | GEO
| S-EPMC4519128 | biostudies-literature
| S-EPMC8363270 | biostudies-literature
| S-EPMC3157172 | biostudies-literature
| S-EPMC8273400 | biostudies-literature